Literature DB >> 21306481

Oral complications in the treatment of cancer patients.

D D Mosel1, R L Bauer, D P Lynch, S T Hwang.   

Abstract

While treatment for cancer in terms of chemotherapy and radiation therapy have evolved significantly since their inception, both of these cancer treatment modalities, especially if used in combination (e.g., as with head and neck cancers), have a very real potential to result in painful and debilitating adverse effects that clearly decrease quality of life and, potentially, increase mortality due to cancer. Herein, we discuss the prevalence and etiology of three broad categories of oral complications found during the treatment of cancer patients: mucositis, dysgeusia, and infectious disease. Lastly, we present therapeutic options that may be helpful in ameliorating these uncomfortable and, sometimes, life-threatening oral complications.
© 2011 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21306481     DOI: 10.1111/j.1601-0825.2011.01788.x

Source DB:  PubMed          Journal:  Oral Dis        ISSN: 1354-523X            Impact factor:   3.511


  29 in total

1.  N-acetyl cysteine in prevention of amphotericin- induced electrolytes imbalances: a randomized, double-blinded, placebo-controlled, clinical trial.

Authors:  Iman Karimzadeh; Hossein Khalili; Simin Dashti-Khavidaki; Ramezanali Sharifian; Alireza Abdollahi; Mehrdad Hasibi; Zahra Khazaeipour; Shadi Farsaei
Journal:  Eur J Clin Pharmacol       Date:  2014-01-21       Impact factor: 2.953

2.  Taste Alteration in Patients Receiving Chemotherapy.

Authors:  Elif Sözeri; Sevinç Kutlutürkan
Journal:  J Breast Health       Date:  2015-04-01

Review 3.  Appropriate and necessary oral care for people with cancer: guidance to obtain the right oral and dental care at the right time.

Authors:  Joel B Epstein; Pelin Güneri; Andrei Barasch
Journal:  Support Care Cancer       Date:  2014-03-28       Impact factor: 3.603

Review 4.  Oral mucosal changes induced by anticancer targeted therapies and immune checkpoint inhibitors.

Authors:  Emmanuelle Vigarios; Joel B Epstein; Vincent Sibaud
Journal:  Support Care Cancer       Date:  2017-02-22       Impact factor: 3.603

5.  Evaluating the additive effect of Persica and chlorhexidine mouthwashes on oral health status of children receiving chemotherapy for their hematomalignancy: A randomized clinical trial.

Authors:  Zahra Bahrololoomi; Azam Sadat-Hashemi; Mohammad Hassan-Akhavan-Karbassi; Yasamin Khaksar
Journal:  J Clin Exp Dent       Date:  2020-06-01

6.  Association between tamoxifen and tooth loss in women with breast cancer.

Authors:  Felipe de Araujo Sensever; Luísa Comerlato Jardim; Kívia Linhares Ferrazzo; Jovito Adiel Skupien; Raquel Pippi Antoniazzi
Journal:  Support Care Cancer       Date:  2022-07-07       Impact factor: 3.359

7.  Oral shedding of human herpesviruses in patients undergoing radiotherapy/chemotherapy treatment for head and neck squamous cell carcinoma.

Authors:  Michelle Palmieri; Victor Adriano de Oliveira Martins; Laura Masami Sumita; Tania Regina Tozetto-Mendoza; Bruna Baraldi Romano; Clarisse Martins Machado; Claudio Sergio Pannuti; Thaís Bianca Brandão; Ana Carolina Prado Ribeiro; Luciana Corrêa; Paulo Henrique Braz-Silva
Journal:  Clin Oral Investig       Date:  2016-12-14       Impact factor: 3.573

Review 8.  Review of the complications associated with treatment of oropharyngeal cancer: a guide for the dental practitioner.

Authors:  Lena Turner; Muralidhar Mupparapu; Sunday O Akintoye
Journal:  Quintessence Int       Date:  2013-03       Impact factor: 1.677

9.  Self-reported oral health and quality of life of postmenopausal breast cancer survivors on aromatase inhibitors and women without cancer diagnoses: a longitudinal analysis.

Authors:  L Susan Taichman; Catherine H Van Poznak; Marita R Inglehart
Journal:  Support Care Cancer       Date:  2016-07-25       Impact factor: 3.603

10.  Dental students' knowledge of characteristics and management of oral complications of cancer therapy.

Authors:  Esin Alpöz; Pelin Güneri; Joel B Epstein; Hülya Cankaya; Damir Osmic; Hayal Boyacıoğlu
Journal:  Support Care Cancer       Date:  2013-06-01       Impact factor: 3.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.